---
$id: https://graph.org.ai/products/commodity/51282934
$type: Product
source: UNSPSC
code: "51282934"
title: "Orbifloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Orbifloxacin

**UNSPSC Code**: 51282934
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C19H20F3N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 660932TPY6, chemically known as 1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-5,6,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid but generally known as orbifloxacin, which bears US NIH Compound Identifier 60605. European Medicines Agency schedules Orbifloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09454MIG. The term ORBIFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, No3, 1993, List 33). ORBIFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule orbifloxacin under HS 29335995 and SITC 51576. As of Q4 2014, ORBIFLOXACIN remains the US FDA Preferred Term for this commodity. Orbifloxacin bears US NLM identifiers UMLS ID C0300903 and NCI Concept Code C72635. SMILES: FC1C2N(C3CC3)CC(C(=O)C2C(F)C(F)C1N1CC(NC(C1)C)C)C(=O)O.

